All In Biotech

Drugs by condition

Drugs approved for hidradenitis suppurativa

Brand-name prescription drugs and biologics whose FDA label lists hidradenitis suppurativa as an approved use. Matched on the label phrases: "hidradenitis suppurativa".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

14

Still marketed, NDA or BLA

Drug classes

3

Novel drugs

3

New molecular entities and new biologics

In development

26

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for hidradenitis suppurativa.

  • Simlandi (Adalimumab-Ryvk) · Alvotech USA INC Feb 23, 2024
  • Idacio (Adalimumab-Aacf) · Fresenius Kabi USA Jan 5, 2024
  • Bimzelx (Bimekizumab-Bkzx) · Ucb INC NovelOct 17, 2023
  • Cosentyx (Secukinumab) · Novartis Pharms Corp Oct 6, 2023
  • Yuflyma (Adalimumab-Aaty) · Celltrion May 23, 2023

All approved drugs for hidradenitis suppurativa, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 0 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Tumor Necrosis Factor Blocker (4)

  • Yusimry Adalimumab-Aqvh · Emerge Bioscience Pte LTD · 2021
  • Hadlima Adalimumab-Bwwd · Samsung Bioepis CO LTD · 2019
  • Hyrimoz Adalimumab-Adaz · Sandoz INC · 2018
  • Amjevita Adalimumab-Atto · Amgen INC · 2016

Interleukin-17A Antagonist (2)

  • Cosentyx Secukinumab · Novartis Pharms Corp · 2015
  • Cosentyx Secukinumab · Novartis Pharms Corp · 2023

Class not listed in FDA's data (8)

  • Bimzelx Bimekizumab-Bkzx · Ucb INC · 2023
  • Humira Adalimumab · Abbvie INC · 2002
  • Simlandi Adalimumab-Ryvk · Alvotech USA INC · 2024
  • Idacio Adalimumab-Aacf · Fresenius Kabi USA · 2024
  • Yuflyma Adalimumab-Aaty · Celltrion · 2023
  • Hulio Adalimumab-Fkjp · Mylan Pharms INC · 2020
  • Abrilada Adalimumab-Afzb · Pfizer INC · 2019
  • Cyltezo Adalimumab-Adbm · Boehringer Ingelheim · 2017

Drugs in development for hidradenitis suppurativa

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • ZasocitinibTAK- 279, NDI-034858Phase 317 trials

    Takeda · Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease

  • PovorcitinibINCB054707, INCB54707Phase 312 trials

    Incyte · Hidradenitis Suppurativa (HS), NonSegmental Vitiligo, Prurigo Nodularis

  • MK-7240PRA023, TulisokibartPhase 310 trials

    Merck & Co. · Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease

  • LutikizumabABT-981Phase 38 trials

    AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis

  • OlatorepatideHS-20094Phase 38 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Type 2 Diabetes, Overweight or Obesity, Overweight or Obesity Without Diabetes

  • SonelokimabPhase 37 trials

    MoonLake Immunotherapeutics AG · Hidradenitis Suppurativa, Arthritis, Psoriatic

  • BFB759Phase 32 trials

    Bluefin Biomedicine, Inc. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)

  • brivekimigSAR442970Phase 25 trials

    Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus

  • MAS825ArumakimigPhase 24 trials

    Novartis · NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations, Still´s Disease, VEXAS Syndrome

  • LT-002-158Phase 23 trials

    Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)

  • ORKA-002Phase 23 trials

    Oruka Therapeutics, Inc. · Plaque Psoriasis, Hidradenitis Suppurativa (HS)

  • QLS12010Phase 23 trials

    Qilu Pharmaceutical Co., Ltd. · Adults With Moderate-to-severe Hidradenitis Suppurativa, Moderate-to-severe Atopic Dermatitis, Rheumatoid Arthritis (RA)

  • CIT-013Phase 22 trials

    Citryll BV · Hidradenitis Suppurativa (HS), Rheumatoid Arthritis

  • CIT-013 dosePhase 22 trials

    Citryll BV · Hidradenitis Suppurativa (HS), Rheumatoid Arthritis

  • EltrekibartLY3041658Phase 22 trials

    Eli Lilly · Ulcerative Colitis, Ulcerative Colitis Chronic, Hidradenitis Suppurativa

  • HB0043Phase 22 trials

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Acne Vulgaris, Hidradenitis Suppurativa

  • SL-325Phase 22 trials

    Shattuck Labs, Inc. · Crohn's Disease, Hidradenitis Suppurativa (HS)

  • SPY002-072SPY072Phase 22 trials

    Spyre Therapeutics, Inc. · Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis

  • TibulizumabZB-106Phase 22 trials

    Zura Bio Inc · Hidradenitis Suppurativa (HS), Systemic Sclerosis (SSc), Scleroderma

  • iscalimabCFZ533Phase 21 trial

    Novartis · Hidradenitis Suppurativa

More on hidradenitis suppurativa: recruiting trials · published research

Related in immunology and inflammation: Rheumatoid arthritis · Plaque psoriasis · Psoriatic arthritis · Atopic dermatitis (eczema) · Crohn's disease · Ulcerative colitis · Ankylosing spondylitis · Lupus (SLE) · Chronic hives (urticaria) · Alopecia areata

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.